Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001735933-20-000003
Filing Date
2020-03-09
Accepted
2020-03-09 14:48:52
Documents
1
Effectiveness Date
2020-03-09
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 4782
  Complete submission text file 0001735933-20-000003.txt   5842
Mailing Address 1392 MADISON AVENUE SUITE 125 NEW YORK NY 10029
Business Address 1392 MADISON AVENUE SUITE 125 NEW YORK NY 10029 9179719655
Redpin Therapeutics, Inc. (Filer) CIK: 0001735933 (see all company filings)

EIN.: 815353627 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-362277 | Film No.: 20697675